The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
The role of the brain reward system in depression
Abstract
The goal of this review is to familiarize the reader about the potential involvement of the brain reward system (BRS) in symptoms of Major Depressive Disorder (MDD). The authors introduce a novel approach to study the pathophysiology of MDD that includes pharmacological probing of BRS pathways (e.g. d-amphetamine, hydromorphone) together with an elicited and measurable behavioral component (e.g. pleasant effects, increased energy, altered cognition). To this date, the major focus of MDD pathophysiology studies has been to characterize biological differences between healthy subjects and depressed patients such as alteration in the monoaminergic and endocrine systems. The relative importance of the various biological changes has not been elucidated, that is, linking these with specific behavioral manifestations in MDD have rarely been attempted. One core symptom of MDD is a decreased experience of pleasure or interest in previously enjoyed activities (i.e. anhedonia) such as work or hobbies, and is accompanied by decreased motivation or drive. The BRS consists of the neural pathways involved in eliciting rewarding experiences in animals and humans. The hypothesis is that altered BRS function may be an underlying brain mechanism of the loss of pleasure/interest experienced in MDD, and will be manifested through an altered response to a BRS probe. The authors have examined BRS function in MDD by introducing a pharmacological probe (i.e. d-amphetamine/d-amph). Amphetamine is defined as a probe due to its ability to release dopamine within major components of the BRS (i.e. the mesocorticolimbic dopamine system.) In addition to the objective pharmacological effects (e.g. altered heart rate), BRS probes like d-amph elicit reliable and measurable behavior, that is, the hedonic effects. A review of the neurobiology of MDD, the BRS, the rationale for implicating the BRS in depressive symptoms, and preliminary data, are presented in this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These systems play key roles in neurotransmission, brain maturation, cortical organisation and behaviours (including social behaviour and repetitive behaviour) [180,181,182,183,184].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
In the citing paper
“Multiple lines of evidence suggest an involvement of dysregulated neurotransmitter systems (serotonergic, oxytocinergic and dopaminergic systems) in autism.”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
Citations
Cites
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Predictive reward signal of dopamine neurons
Schultz, W. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.1.1 · Cited by 4,564
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176
Ongur, D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.206 · Cited by 2,627
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
McNair, D. M. (1992) · Medical Entomology and Zoology · Cited by 2,527
Research works printed but not linked: 7
- 1999, Guidelines for the Diagnosis and Pharmacological Treatment of Depression
- Cardenas, 2000, Dopaminergic activity in depressed smokers, Br. J. Clin. Pharmacol., 425
- Herbrener, 2000, Anhedonia in schizophrenia: Longitudinal Analyses, American Psychiatric Association Conference. Conference Proceeding
- Jasinski, 1989, Human abuse liability assesment by measurement of subjective and physiological effects. Testing for abuse liability of drugs in humans, NIDA Res. Monogr., 93, 73
- Segal, 1996, Biobehavioral effects of psychoactive drugs (Chapter 16). In Neurobehavioural toxicology and addiction, 451
- Tremblay, 2000, Response to d-amphetamine is altered in Major Depressive Disorder (MDD), Clin. Pharmacol. Ther., 67, 130
- Tremblay, 2000, Probing the Brain Reward System in Major Depressive Disorder: Altered response to d-amphetamine
Cited by
Sorted by citations
Items 201–244 of 244
Traditional and Novel Possible Targets for Antidepressant Drugs
Palazidou, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-14021-6_2 · Cited by 3
Morales‐Narváez, E., & Merkoçi, A. (2014) · Nanostructure science and technology · doi:10.1007/978-1-4614-2140-5_7 · Cited by 3
The Effect of Depression on Motivation to Study
Shiwaruangrote, P. (2022) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v5-i6-48 · Cited by 3
Mota-Pereira, J., Silvério, J., Fonte, D., Carvalho, S., Ramos, J., & Ribeiro, J. C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 3
Triple‐Uptake Inhibitors (Broad‐Spectrum Antidepressants)
Skolnick, P. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch18 · Cited by 3
Pui, T. S. (2019) · Nanomedicine & Nanotechnology Open Access · doi:10.23880/nnoa-16000169 · Cited by 1
Treatment of Depression in Medical Illness
Raison, C. L., Purselle, D. C., Capuron, L., & Miller, A. H. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch9 · Cited by 2
Neuropsychologie der Motivation
Gauggel, S. (2010) · Springer eBooks · doi:10.1007/978-3-540-72340-0_5 · Cited by 2
Baskaran, A. (2016) · QSpace (Queen's University Library) · Cited by 2
Kaiser, A. J. E., Shippen, N. A., Tufty, L. M., Lejeune, J., Zolli, N., & Meinzer, M. C. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-41709-2_14 · Cited by 2
ERK2 Signaling in the Nucleus Accumbens Facilitates Stress Susceptibility and Cocaine Reinstatement
Parise, L. F., Iñiguez, S. D., Warren, B. L., Parise, E. M., Bachtell, R. K., Dietz, D., Nestler, E. J., & Bolaños‐Guzmán, C. A. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100416 · Cited by 1
Animal Models of Neurobehavioral Trait Dimensions
Bartling-John, E., Leong, K.-C., Ross, C. N., Colman, R. J., & Phillips, K. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-77967-1_3 · Cited by 1
In vivo imaging of dopamine and serotonin release: response to psychopharmacological challenges
de Haes, J. I. U. (2000) · Cited by 1
Esumi, S., Sagara, H., Nakamoto, A., Kawasaki, Y., Gomita, Y., & Sendo, T. (2013) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.125.205 · Cited by 1
Li, Q.-J., & An, S.-C. (2010) · Zoological Research · doi:10.3724/sp.j.1141.2009.06653 · Cited by 1
Major Depressive Disorder in Neuroimaging: What is Beyond Fronto-limbic Model?
Lai, C. (2018) · Current Psychiatry Research and Reviews · doi:10.2174/1573400515666181213155225 · Cited by 1
Rizvi, S. J., Salomons, T. V., Konarski, J. Z., Downar, J. H., Giacobbe, P., McIntyre, R. S., & Kennedy, S. H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.07.033 · Cited by 1
Duvenhage, I. (2010) · Boloka Institutional Repository (North-west University) · Cited by 1
In search of animal models for male sexual dysfunction
Chan, J. S. W. (2008) · Utrecht University Repository (Utrecht University) · Cited by 1
Lazowski, L. (2009) · Cited by 1
Biomedical links between cognitions and behaviour
Gill, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-8800-0.50007-0
Neuropharmacogenetics of Major Depression: Has the Time Come to Take both Sexes into Account?
Pothitos, M., Sanoudou, D., Dalla, C., & Papadopoulou‐Daifoti, Z. (2012) · InTech eBooks · doi:10.5772/26634
Balducci, X. L. (2009) · TSpace (University of Toronto)
ExtracellularSignal-RegulatedKinase-2withintheVentral TegmentalAreaRegulatesResponsestoStress
Warren, B. L., & Neve, R. L. (2010)
INSTITUTO DE NEUROCIENCIAS "FEDERICO OLÓRIZ"
Medicina, F. D. (2008)
Psychobiological Processes and Therapies in Depression
Cristancho, P., & Thase, M. E. (2015) · Wiley eBooks · doi:10.1002/9781119114482.ch4
Physical treatments in bipolar disorder
Masurier, M. L., Herrmann, L. L., Coulson, L. K., & Ebmeier, K. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.007
Odrębności między depresją w chorobie afektywnej dwubiegunowej i jednobiegunowej
Cuellar, A. K., Johnson, S. L., & Winters, R. W. (2006) · Via Medica Journals
Neurobiological Consequences of Fluoxetine Exposure during Adolescence
Iñiguez, S. D. (2011)
Opposing Effects of Acute Stress in a Rodent Model of Gambling Behaviour
Hedayatmofidi, P. S. (2015) · TSpace (University of Toronto)
The signal for good news and value of information in human choice behavior
Sawalha, J. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3q23rg31
The Functional Domain of Self-Other Regulation
Lorenzini, N., Fonagy, P., & Luyten, P. (2021) · Depression and personality · doi:10.1007/978-3-030-70699-9_4
Song, N., Yan, G., Shanshan, L., Yang, S., Yuan, C., & Wenyu, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.01.470503
Parise, L. F., Iñiguez, S. D., Warren, B. L., Parise, E. M., Bachtell, R. K., Dietz, D., Nestler, E. J., & Bolaños‐Guzmán, C. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.03.560689
Imaging of brain electric field networks with spatially resolved EEG
Frank, L. R., Galinsky, V. L., Krigolson, O. E., Tapert, S. F., Bickel, S., & Martı́nez, A. (2025) · eLife · doi:10.7554/elife.100123.3
Imaging of brain electric field networks with spatially resolved EEGPreprint
Frank, L. R., Galinsky, V. L., Krigolson, O. E., Tapert, S. F., Bickel, S., & Martı́nez, A. (2024) · eLife · doi:10.7554/elife.100123
Imaging of brain electric field networksPreprint
Frank, L. R., Galinsky, V. L., Krigolson, O. E., Tapert, S. F., Bickel, S., & Martı́nez, A. (2024) · eLife · doi:10.7554/elife.100123.1
Kritzer, M. D., Maddox, S. A., Chen, M. X., Dan, S., Covington, H. E., Miczek, K. A., Camprodon, J. A., Klengel, T., & Ressler, K. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.12.637719
Imaging of brain electric field networks with spatially resolved EEGPreprint
Frank, L. R., Galinsky, V. L., Krigolson, O. E., Tapert, S. F., Bickel, S., & Martı́nez, A. (2025) · eLife · doi:10.7554/elife.100123.2
Metadata
- Authors
- Naranjo, C. A., Tremblay, L. K., & Busto, U. E.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Naranjo, Claudio A.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 25
- Issue
- 4
- Pages
- 781-823
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2040295810
- Cited by
- 245
- References
- 271
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 9 · 2018: 13 · 2017: 11 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 13 · 2012: 13
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- brain reward system, major depressive disorder, anhedonia, dopamine, mesocorticolimbic dopamine system, amphetamine challenge, hydromorphone, motivation, depression pathophysiology
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Animals, Brain, Brain Chemistry, Depressive Disorder, Humans, Reward
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
